XRTX Stock Analysis: Buy, Sell, or Hold?
XRTX - XORTX Therapeutics Inc. Common Stock
$0.50
0.01 (1.94%)
▲
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 24, 2026
Get Alerted When XRTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: XRTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: XRTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: XRTX is currently trading at $0.50, which is considered oversold relative to its 30-day fair value range of $0.54 to $0.60.
Technical Outlook: Technically, XRTX is in a strong downtrend. Immediate support is located at $0.46, while resistance sits at $0.58.
Market Sentiment: XRTX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $14.25 (+2753.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, XRTX is in a strong downtrend. Immediate support is located at $0.46, while resistance sits at $0.58.
Market Sentiment: XRTX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $14.25 (+2753.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.54 -
$0.60
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
Holding XRTX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 2753.8% below Wall St target ($14.25)
- CAUTION: 5-day price weakness (-12.4%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$0.54 -
$0.60
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.46
Resistance Level
$0.59
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-1.04
Wall Street Target
$14.25
(+2753.8%)
Earnings Growth (YoY)
-97.2%
Last updated: January 31, 2026 9:18 PM ET
Data refreshes hourly during market hours. Next update: 10:18 PM
Data refreshes hourly during market hours. Next update: 10:18 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XRTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 59 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$117 | 59 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$112 | 52 HOLD |
Advanced XRTX Option Strategies
Professional options setups generated by AI based on today's XRTX price and gamma walls.
